← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Radiopharmaceutical Imaging And Dosimetry, Llc
Baltimore, MD
$8,143,577
Total funding
9
Grants
Funding over time
peak $3.3M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,143,577 · 9
By mechanism
R44$4,519,312 · 3
N44$1,999,796 · 1
R43$1,025,728 · 3
N02$299,466 · 1
N43$299,275 · 1
Investigators at Radiopharmaceutical Imaging And Dosimetry, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
TOPIC 368: TREATMENT OPTIMIZATION BY COMBINED A-EMITTER (ARPT)/RADIOTHERAPY (XRT) DOSIMETRY FOR PROSTATE CANCER PATIENTS$1,999,796
N44 · FY2019 · CA
Cloud/Web-Based Platform for Quantitative SPECT Reconstruction of Therapeutic Radionuclides$1,003,173
R44 · FY2025 · CA
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$999,998
R44 · FY2019 · CA
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$898,497
R44 · FY2024 · CA
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$749,606
R44 · FY2025 · CA
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$706,019
R44 · FY2021 · CA
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy$300,000
R43 · FY2017 · CA
Quantitative SPECT of Difficult to Image Therapeutic Radionuclides: An Extensible Cloud-Based Framework$299,995
R43 · FY2018 · CA
SOFTWARE FOR OPTIMAL COMBINATION OF EXTERNAL BEAM RADIOTHERAPY (XRT) AND RADIOPHARMACEUTICAL THERAPY (RPT)$299,466
N02 · FY2017 · CA
SBIR PHASE I TOPIC 392: TARGETED RADIONUCLIDE THERAPY OF METASTATIC LIVER CANCER: PATIENT SPECIFIC OPTIMIZATION$299,275
N43 · FY2019 · CA
Cloud/Subscription based, Customer-Responsive Dosimetry Tool for alpha-Particle Emitters$293,774
R43 · FY2018 · CA
Development and Validation of a Collaborative Web/Cloud-Based Dosimetry System for Radiopharmaceutical Therapy.$162,019
R44 · FY2020 · CA
Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical Therapy$131,959
R43 · FY2018 · CA